HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma
Condition(s):EpendymomaLast Updated:January 23, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):EpendymomaLast Updated:January 23, 2024Active, not recruiting
Condition(s):EpendymomaLast Updated:March 2, 2015Terminated
Condition(s):EpendymomaLast Updated:February 23, 2022Terminated
Condition(s):Fossa EpendymomaLast Updated:June 22, 2023Recruiting
Condition(s):EpendymomaLast Updated:August 24, 2023Active, not recruiting
Condition(s):Ependymoma, Recurrent Childhood; EpendymomaLast Updated:March 15, 2024Completed
Condition(s):Anaplastic Ependymoma; EpendymomaLast Updated:September 14, 2023Recruiting
Condition(s):Recurrent Childhood EpendymomaLast Updated:August 29, 2023Completed
Condition(s):EpendymomaLast Updated:November 3, 2023Recruiting
Condition(s):Childhood EpendymomaLast Updated:September 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.